Skip to main content
2026 CRT Conference Main banner

CRT 2026

Innovation and Technology

Session:: Medtech Mitral Tricuspid Valve and LAAO Regulatory Science Town Hall [Non-CME]

Panel Discussion | The Direction of Future of Studies of Tricuspid Valve Interventions

Monday, March 9, 2026
2:30 PM - 3:00 PM EST
Location: International Ballroom East

    Moderator(s)

  • Azeem Latib, MD

    Director, Interventional Cardiology & Structural Heart Interventions
    Montefiore Medical Center
    Scarsdale, New York, United States

    Disclosure information not submitted.

  • Changfu Wu, PhD

    SBRBPAS Expert
    Food and Drug Administration
    Silver Spring, Maryland, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Amr Abbas, MD

    Director, Structural Heart and Cardiovascular Research
    Corewell Health, Michigan, United States

    Disclosure(s): Anteris: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Suzanne V. Arnold, MD

    Professor
    Saint Luke's Mid America Heart Institute
    Kansas City, Missouri, United States

    Disclosure(s): No financial relationships to disclose

  • Steven F. Bolling, MD

    Professor of Cardiac Surgery
    University of Michigan Hospital
    Ann Arbor, Michigan, United States

    Disclosure information not submitted.

  • Maurice Sarano, MD

    Senior Scientist
    Minneapolis Heart Institute
    Minneapolis, Minnesota, United States

    Disclosure(s): HighLifeSAS: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Lars Sondergaard, MD

    Chief Medical Officer
    Abbott Structural Heart
    Santa Clara, California, United States

    Disclosure(s): Abbott: Employee (Ongoing)

  • Kevin G. Soucy, PhD

    Principal Consultant
    CardioMed Device Consultants, LLC, United States

    Disclosure(s): Many cardiovascular device manufacturers: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Mark Reisman, MD, FACC

    Director, Structural Heart Disease
    NYP Cornell
    new york , New York, United States

    Disclosure information not submitted.

Disclosure(s):
Rebecca T. Hahn, MD: Abbott Vascular,: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Phillips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Amr Abbas, MD: Anteris: Consulting Fees (e.g., advisory boards) (Ongoing)
Suzanne V. Arnold, MD: No financial relationships to disclose
Maurice Sarano, MD: HighLifeSAS: Consulting Fees (e.g., advisory boards) (Ongoing)
Lars Sondergaard, MD: Abbott: Employee (Ongoing)
Kevin G. Soucy, PhD: Many cardiovascular device manufacturers: Consulting Fees (e.g., advisory boards) (Ongoing)